HLA Journal

In 2006 HLA (previously Tissue Antigens) was made the house journal of EFI. HLA publishes full-length original articles, brief communications, commentaries and occasional reviews on research in: immunogenetics of cell surface antigens; ontogeny and phylogeny of the immune system; immunogenetics of cell interactions; functional aspects of cell surface molecules and their natural ligands, such as cytokines, adhesion molecules and activation antigens; role of tissue antigens in immune reactions in vitro and in vivo, including experimental and clinical transplantation; and relationships between normal tissue antigens and tumor-associated antigens.

The journal emphasizes genetic control of immune response, disease susceptibility and genetics, biochemistry and molecular biology of alloantigens and leukocyte differentiation. Manuscripts are invited on molecules expressed on lymphoid cells, myeloid cells, platelets and non-lineage-restricted antigens. The immunogenetics of histocompatibility antigens in humans and experimental animals and their tissue distribution, regulation and expression in normal and malignant cells and antigens as markers for disease are of major interest.

The special Issue (HLA, Vol. 103 Issue S1, May 2024): Abstracts for the 37th European Immunogenetics and Histocompatibility Conference in Geneva, Switzerland May 20-23, 2024 has now been published. To view the abstractbook click here.

Please login to your EFI account on the homepage to get free access to the HLA Journal.

The EFI Nominated HLA Editorial Board Members are: